These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27226719)

  • 21. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM; Malt UF; Opjordsmoen S
    BMC Psychiatry; 2011 Feb; 11():25. PubMed ID: 21314980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting health-related quality of life in people living with HIV in Nepal: mental health disorders and substance use determinants.
    Pokhrel KN; Sharma VD; Shibanuma A; Pokhrel KG; Mlunde LB; Jimba M
    AIDS Care; 2017 Sep; 29(9):1137-1143. PubMed ID: 28547996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Confirming the factor structure of a generic quality of life instrument among pre-treatment substance use disorder patients.
    Muller AE; Skurtveit S; Clausen T
    Health Qual Life Outcomes; 2019 May; 17(1):84. PubMed ID: 31101049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-Related Quality of Life in Male Patients under Treatment for Substance Use Disorders with and without Major Depressive Disorder: Influence in Clinical Course at One-Year Follow-Up.
    Marquez-Arrico JE; Navarro JF; Adan A
    J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32993107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of categorical diagnoses and psychopathologies with quality of life in patients with depression, anxiety, and somatic symptoms: A cross-sectional study.
    Tu CY; Liao SC; Wu CS; Chiu YT; Huang WL
    J Psychosom Res; 2024 Jul; 182():111691. PubMed ID: 38718690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Change in psychosocial factors connected to coping after inpatient treatment for substance use disorder: a systematic review.
    Johannessen DA; Nordfjærn T; Geirdal AØ
    Subst Abuse Treat Prev Policy; 2019 May; 14(1):16. PubMed ID: 31053153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study.
    Lana F; Sánchez-Gil C; Adroher ND; Pérez V; Feixas G; Martí-Bonany J; Torrens M
    Neuropsychiatr Dis Treat; 2016; 12():1477-87. PubMed ID: 27382290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression Negatively Impacts Dyadic Quality of Life Following Neuro-ICU Admission: A Prospective Study of Cognitively Intact Patients and Caregivers.
    Quinn PA; Mace RA; Presciutti A; Vranceanu AM
    Int J Behav Med; 2024 Feb; 31(1):97-108. PubMed ID: 36754950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance use disorders in patients with intellectual disability admitted to psychiatric hospitalisation.
    Salavert J; Clarabuch A; Fernández-Gómez MJ; Barrau V; Giráldez MP; Borràs J
    J Intellect Disabil Res; 2018 Nov; 62(11):923-930. PubMed ID: 29961996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance use disorders among personality disordered patients admitted for day hospital treatment. Implications for service developments.
    Karterud S; Arefjord N; Andresen NE; Pedersen G
    Nord J Psychiatry; 2009; 63(1):57-63. PubMed ID: 19172500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult attention-deficit/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug.
    Federico A; Mantovani E; Casari R; Bertoldi A; Lugoboni F; Tamburin S
    J Neural Transm (Vienna); 2021 Jul; 128(7):1109-1119. PubMed ID: 33331955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life in hoarding: A comparison to chronic conditions with high disease burden.
    Nutley SK; Read M; Eichenbaum J; Nosheny RL; Weiner M; Mackin RS; Mathews CA
    J Psychiatr Res; 2022 May; 149():68-75. PubMed ID: 35255385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary and secondary substance misusers: do they differ in substance-induced and substance-independent mental disorders?
    Bakken K; Landheim AS; Vaglum P
    Alcohol Alcohol; 2003; 38(1):54-9. PubMed ID: 12554609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse after inpatient substance use treatment: A prospective cohort study among users of illicit substances.
    Andersson HW; Wenaas M; Nordfjærn T
    Addict Behav; 2019 Mar; 90():222-228. PubMed ID: 30447514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-event quality of life and its influence on the post-event quality of life among patients with ST elevation and non-ST elevation myocardial infarctions of a premier province of Sri Lanka.
    Mahesh PKB; Gunathunga MW; Jayasinghe S; Arnold SM; Haniffa R; De Silva AP
    Health Qual Life Outcomes; 2017 Aug; 15(1):154. PubMed ID: 28764724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing pre-stroke and post-stroke quality of life among stroke survivors in a lower middle-income country.
    Mahesh PKB; Gunathunga MW; Jayasinghe S; Arnold SM; Liyanage SN
    Neurol Sci; 2018 Feb; 39(2):287-295. PubMed ID: 29103178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The phenotype of recovery II: The association between delay discounting, self-reported quality of life, and remission status among individuals in recovery from substance use disorders.
    Athamneh LN; Freitas Lemos R; Basso JC; Tomlinson DC; Craft WH; Stein MD; Bickel WK
    Exp Clin Psychopharmacol; 2022 Feb; 30(1):59-72. PubMed ID: 33001696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mental distress following inpatient substance use treatment, modified by substance use; comparing voluntary and compulsory admissions.
    Pasareanu AR; Vederhus JK; Opsal A; Kristensen Ø; Clausen T
    BMC Health Serv Res; 2017 Jan; 17(1):5. PubMed ID: 28049461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.